Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-052145
Filing Date
2007-03-12
Accepted
2007-03-12 15:53:51
Documents
7
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ON FORM 10-K d10k.htm 10-K 1097952
2 LIST OF SUBSIDIARIES dex211.htm EX-21.1 739
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1985
4 CERTIFICATION OF CEO, AS REQUIRED BY RULE 13A-14(A) dex311.htm EX-31.1 6237
5 CERTIFICATION OF VP AND CFO, AS REQUIRED BY RULE 13A-14(A) dex312.htm EX-31.2 6267
6 CERTIFICATION OF CFO AS REQUIRED BY RULE 13A-14(B) dex321.htm EX-32.1 4233
7 CERTIFICATION OF VP AND CFO, AS REQUIRED BY RULE 13A-14(B) dex322.htm EX-32.2 4260
  Complete submission text file 0001193125-07-052145.txt   1123178
Mailing Address 650 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 650 GATEWAY BOULEVARD -- SOUTH SAN FRANCISCO CA 94080 6506249600
ANESIVA, INC. (Filer) CIK: 0001131517 (see all company filings)

EIN.: 770503399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50573 | Film No.: 07687638
SIC: 2834 Pharmaceutical Preparations